Nature reports single-cell protein advances

Nature on Sept. 7 published a technology feature reporting that single-cell proteomics has advanced to the point where researchers can identify thousands of proteins in individual cells. The article, by Michael Eisenstein, said the gains come from rapid improvements in mass spectrometry sensitivity and related workflows, opening a way to study development and disease through proteins rather than transcripts alone. Nature described the work as exposing mechanisms that were previously hidden when researchers relied on bulk measurements or RNA-only readouts. ### Why are researchers pushing beyond single-cell RNA data? Single-cell RNA sequencing has dominated cell-atlas work because it scales well, but protein levels do not map cleanly onto messenger RNA abundance, according to a 2023 Nature Methods review on single-cell proteomics. That review said proteins offer added information because they are the direct effectors of cell function and because post-translational modifications are not captured by transcript counts. (nature.com) Nature’s Sept. 7 feature said the new proteomics methods are now revealing “hidden mechanisms” in development and disease at cellular resolution. That framing fits a broader shift in the field toward measuring the molecules that carry out signaling, metabolism and structural work inside cells, rather than inferring those processes from RNA alone. ### What changed technically to make this possible? Mass spectrometry is the main driver of the recent progress. (nature.com) A 2025 Nature review said advances in sample preparation, instrumentation and data-acquisition strategies have markedly increased sensitivity, enabling single-cell proteomics and tissue spatial profiling. Sample handling has been a central bottleneck because proteins from one cell are present in minute amounts and can be lost on tube and chip surfaces. (nature.com) A 2026 Nature Communications paper describing an “all-in-one” preparation method said reducing adsorption losses improved protein recovery for quantitative single-cell profiling. Earlier work in Nature Communications also described integrated microfluidic chips for all-in-one sample preparation coupled to data-independent acquisition mass spectrometry. (nature.com) ### How deep is single-cell protein profiling now? Nature Methods wrote in 2025 that the field had entered an era of “deep single-cell proteomics,” with advances allowing quantification of about half of the expressed proteome in an individual cell. That is a different scale from early single-cell protein assays, which were often limited to preselected panels or much shallower coverage. A 2024 Nature Communications study reported quantifying up to 3,000 protein groups in a mammalian cell with a pick-up workflow, while Nature’s Sept. 7 feature said researchers can now identify thousands of proteins in individual cells. (nature.com) Taken together, those reports show that the field has moved from proof-of-concept measurements toward broader proteome coverage in single cells. ### Where are these methods already being used? (nature.com) The developing human brain is one example. A Nature Biotechnology paper published earlier this year reported a single-cell proteomic landscape of the developing human brain and said the optimized workflow generated a high-resolution map of protein abundance and dynamics in that tissue. Nature’s 2025 review also said single-cell and spatial proteomics are moving toward clinical applications, including biomarker discovery and diagnostics, although it also noted continuing challenges in throughput, robustness and implementation. (nature.com) That places the latest Sept. 7 feature inside a broader push to apply these tools across basic biology and medicine. ### What should readers watch next? Nature’s Sept. 7 feature is the clearest current marker that the journal sees single-cell proteomics as moving into a more mature phase. (nature.com) The next concrete signals are likely to come from new tissue atlases, disease-focused studies and methods papers that show whether high-depth protein measurements can be reproduced across larger sample sets and clinical material. Michael_W_Deem’s Sept. 7 X post linked directly to the Nature item’s DOI, providing one public trail for how the paper began circulating outside the journal. (nature.com 1) (nature.com 2)